Boston Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-6,465
| Closed | -$708K | – | 641 |
|
|
2017
Q4 | $708K | Buy |
+6,465
| New | +$708K | 0.02% | 434 |
|
|
2017
Q2 | – | Sell |
-9,580
| Closed | -$862K | – | 649 |
|
|
2017
Q1 | $862K | Sell |
9,580
-12,035
| -56% | -$1.08M | 0.02% | 379 |
|
|
2016
Q4 | $1.65M | Buy |
21,615
+1,650
| +8% | +$126K | 0.04% | 309 |
|
|
2016
Q3 | $1.66M | Buy |
19,965
+15,895
| +391% | +$1.32M | 0.04% | 298 |
|
|
2016
Q2 | $336K | Buy |
+4,070
| New | +$336K | 0.01% | 574 |
|